Why the study?
Obesity is a major risk factor for AMI, but the interplay between metabolic health and obesity on AMI mortality remains controversial.
Does metabolically-healthy-obese status improve short- and long-term all-cause mortality in acute myocardial infarction patients compared to metabolically-healthy-normal-weight status?
Does metabolically-healthy-obese status improve short- and long-term all-cause mortality in acute myocardial infarction patients compared to metabolically-healthy-normal-weight status?
Obesity does not independently confer a survival advantage in AMI patients after adjusting for confounders, though it may worsen outcomes in specific demographic subgroups such as female and Malay patients.
MHO status was not independently linked to AMI mortality after adjustment; leaves open sex- and ethnicity-specific risks in females and Malays.
Introduction: Obesity is an important risk factor for acute myocardial infarction (AMI), but the interplay between metabolic health and obesity on AMI mortality has been controversial. In this study, we aimed to elucidate the risk of short- and long-term all-cause mortality by obesity and metabolic health in AMI patients using data from a multi-ethnic national AMI registry. Methods: A total of 73,382 AMI patients from the national Singapore Myocardial Infarction Registry (SMIR) were included. These patients were classified into four groups based on the presence or absence of metabolic diseases, diabetes mellitus, hyperlipidaemia, and hypertension, and obesity: (1) metabolically-healthy-normal-weight (MHN); (2) metabolically-healthy-obese (MHO); (3) metabolically-unhealthy-normal-weight (MUN); and (4) metabolically-unhealthy-obese (MUO). Results: MHO patients had reduced unadjusted risk of all-cause in-hospital, 30-day, 1-year, 2-year, and 5-year mortality following the initial MI event. However, after adjusting for potential confounders, the protective effect from MHO on post-AMI mortality was lost. Furthermore, there was no reduced risk of recurrent MI or stroke within 1-year from onset of AMI by the MHO status. However, the risk of 1-year mortality was higher in female and Malay AMI patients with MHO compared to MHN even after adjusting for confounders. Conclusion: In AMI patients with or without metabolic diseases, the presence of obesity did not affect mortality. The exception to this finding were female and Malay MHO who had worse long-term AMI mortality outcomes when compared to MHN suggesting that the presence of obesity in female and Malay patients may confer worsened outcomes.
No takes yet. Share an insight, caveat, or question.
Sia et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: